News Archives - Page 41 of 1149 - BioHealth Innovation

News

Immunomic Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma Member Discounts – Maryland Tech Council

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 8, 2022

Cursor and IPO market in a wait and see period EY Americas IPO leader says

News

IPO market in a ‘wait-and-see period,’ EY Americas IPO leader says

EY Americas IPO Leader Rachel Gerring joins Yahoo Finance Live to discuss…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 8, 2022

News

U.S. Department of Commerce Announces Winners of American Rescue Plan $500 Million Good Jobs Challenge to Expand Employment Opportunities | U.S. Economic Development Administration

WASHINGTON – Today, U.S. Secretary of Commerce Gina Raimondo announced grant awards…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 8, 2022

Emocha Health has patients record videos of themselves taking a medication and asking questions about their treatment, which are then reviewed by a live team to ensure adherence and resolve any issues. CEO Sebastian Seiguer said it's a more effective approach than others that rely on financial incentives or prescription refill rates. (emocha Health)

News

Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence | Fierce Healthcare

Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

Cursor and Emergent BioSolutions unveils 7th pandemic CDMO contract this time for Humanigen s late stage antibody hopeful Fierce Pharma

News

Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma

Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

BioTalk logo_226

News

“BioTalk with Rich Bendis” Podcast Featured in BioBuzz Podcasts to Follow Now

In a job market that’s become increasingly competitive and employer-driven, it’s imperative…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

News

REGENXBIO Announces Intention to File a Biologics License Application Using the Accelerated Approval Pathway for RGX-121, an AAV Therapeutic for the Treatment of MPS II

FDA will consider an accelerated approval pathway for RGX-121; BLA filing expected…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

News

NIH Applicant Assistance Program Accepting Applications

The National Institutes of Health (NIH) Applicant Assistance Program (AAP) is designed…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

News

Emergent BioSolutions inks deal for smallpox newcomer Tembexa

Emergent BioSolutions, already flush with products against public health threats like anthrax…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

News

GSK enters agreement with 12 EU countries – BioProcess InsiderBioProcess International

GlaxoSmithKline (GSK) has signed an agreement to reserve, produce, and supply its…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

Previous 1 … 39 40 41 42 43 … 1,149 Next

© 2024 BioHealth Innovation.